Amanda Hewes, education program manager at ChristianaCare’s Gene Editing Institute, was named one of the 2023 Outstanding Delaware Women in STEM by Million Women Mentors, an international movement dedicated to encouraging girls and women to pursue careers in science, technology, engineering and math.
Fox Chase Cancer Center and Temple Health welcomed State Representative Kevin Boyle and State Senators Jimmy Dillon and Christine Tartaglione to the Fox Chase campus to thank them for their support in securing $1.5 million in funding for the modernization of Fox Chase research facilities.
The Winship Cancer Institute at Emory Midtown will open for patients on May 9.
Theresa J. FrancoF. Marc StewartDouglas E. WoodDonna M. PowellThe National Comprehensive Cancer Network has announced the 2023 recipients of awards honoring individuals who improved the lives of people with cancer over the past year.
Karine Sargsyan, formerly director of one of the world’s largest clinical biobanks, was named scientific director of Cedars-Sinai Cancer’s OncoBiobank.
Anna Marie Skalka, senior advisor to the president and professor emerita, was recognized with the Stanley P. Reimann Honor Award, Fox Chase Cancer Center’s highest distinction.
Abigail T. Berman was named assistant professor in the Department of Radiation Oncology at Fox Chase Cancer Center. Berman will focus on caring for patients with thoracic and gastrointestinal cancers.
The Lymphoma Research Foundation awarded 27 research grants in 2023, totaling to $5.4 million, to support lymphoma research. The 2023 LRF grantee class represents 18 medical and academic institutions across North America.
The American College of Surgeons’ Commission on Cancer and Cancer Research Program established a Survivorship Services Survey among its CoC-accredited hospitals and cancer centers.
New York Proton Center, WiTT Group partner to help patients navigate non-clinical challenges of care
The New York Proton Center and the WiTT Group Inc. are partnering to offer the WiTT Support Registry to provide patients with non-clinical support during proton therapy treatment.
